By API User
14 Jan 2026 New global climate data released today by the Copernicus Climate Change Service confirms that 2025 was among the hottest years ever recorded, marked by extreme heat, oceanic warming and escalating climate impacts driven by the burning of fossil fuels. Climate scientists and frontline experts say the findings confirm climate change is not … Continued
By API User
Australian company OmnigeniQ has revealed the first computer model of a human protein as it exists in the body, confirming that native protein topology can be calculated directly from physics. The breakthrough was achieved using the company’s physics-based Deterministic Intelligence model that shows proteins in their native, hydrated, dynamic form – something existing tools cannot do. … Continued
By API User
Researchers have found the benefits of graded sensorimotor retraining for people with chronic low back pain are likely to be similar across a range of people, rather than being limited to specific subgroups. Low back pain affected 619 million people worldwide in 2020 and contributes the largest share of the disability burden. The research investigated … Continued
By API User
Company outlines foundational hematology leadership, multiple 2026 data catalysts, a unique global clinical development superhighway, and continued financial excellence SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will outline the pillars of its growing global oncology leadership during its presentation today at the 44th Annual J.P. … Continued
By API User
A new international study led by researchers from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has developed the first practical, five-year dementia risk prediction tool for stroke survivors – using only information that’s routinely collected in hospitals and clinics. Published on 12 January 2026 in Neurology®, the medical journal of the American Academy of … Continued
By API User
HIGHLIGHTS Record December quarter with global sales of US$6.1 million, up 38% on pcp and 25% on the September 2025 quarter Global six-month sales of US$10.9 million, up 29% on pcp Last Twelve Months (LTM) global sales of ~US$21 million (A$32.2 million), up 24% on prior twelve months and three times higher than the industry … Continued
By API User
13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access … Continued
By API User
Dementia Australia has today opened applications for a new round of Community Engagement grants for up to 12 dementia-friendly community initiatives. Dementia Australia CEO Professor Tanya Buchanan said community groups could apply for up to $10,000 for project ideas that supported their local community to become dementia-friendly. “For this year’s grants we have a special focus on people living with young onset dementia and young carers,” Professor Buchanan said. “We want to see projects that … Continued
By API User
Key points The Tibetan Plateau’s elevation was the main driver behind the Asian monsoon’s development and expansion Initially, weaker summer rains were confined to East Asia before spreading across South Asia as the plateau continued to rise Falling carbon dioxide levels later in the late Miocene influenced monsoon intensity, but tectonic uplift remained the dominant … Continued
By API User
Not intended for Canada-, UK- or US-based media DARMSTADT, Germany–BUSINESS WIRE– Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on … Continued
